If you've been diagnosed with obstructive sleep apnea (OSA), you know that a continuous positive airway pressure (CPAP) ...
Currently, of the handful of FDA-approved implantable sleep apnea devices on the market, Inspire and Remede, a phrenic ...
For many children with obstructive sleep apnea (OSA), adenotonsillectomy (T&A) improves sleep efficiency (SE) and resolves ...
LivaNova has published 12-month data supporting its proximal hypoglossal nerve stimulation (pHGNS) system for sleep apnea.
A randomized controlled trial evaluating the safety and efficacy of proximal hypoglossal nerve stimulation, or pHGNS, (an ...
Southern California Pulmonary and Sleep Disorders Medical Center has announced expanded access to Inspire therapy, offering a ...
MellingMedical today announced a new strategic relationship with TAP Sleep Care, a leader in innovative sleep apnea solutions ...
Explore the best Apple Watch Ultra 3 alternatives, including high-performance models from Samsung, Garmin, and Huawei ...
NyxoahtoReleaseFirst Quarter 2026 Financial Results on May 12, 2026Mont-Saint-Guibert, Belgium – April 28, 2026, 10:05pm CET / 4:05pm ET – Nyxoah ...
The FDA approved the first-ever medication for obstructive sleep apnea in December 2024, expanding a treatment landscape that has long centered on continuous positive airway pressure machines.
With appropriate introduction of oral appliance therapy, more patients are seeing success in navigating sleep disorders and other comorbidities.